Ashland Inc reports results for the quarter ended June 30 - Earnings Summary
Ashland Inc reports results for the quarter ended June 30 - Earnings Summary
Ashland Inc ASH.N reported quarterly adjusted earnings of $1.02 per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $1.04. The mean expectation of ten analysts for the quarter was for earnings of 99 cents per share. Wall Street expected results to range from 59 cents to $1.19 per share.
Revenue rose 7.3% to $497.00 million from a year ago; analysts expected $485.98 million.
Ashland Inc's reported EPS for the quarter was 35 cents.
The company reported quarterly net income of $16 million.
Ashland Inc shares had risen by 0.7% this quarter and gained 13.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 17.2% in the last three months.
In the last 30 days, five analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the diversified chemicals peer group is also "buy"
Wall Street's median 12-month price target for Ashland Inc is $74.00, about 8.1% above its last closing price of $68.01
This summary was machine generated from LSEG data July 28 at 11:05 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | 0.99 | 1.02 | Beat |
Mar. 31 2026 | 0.94 | 0.91 | Missed |
Dec. 31 2025 | 0.26 | 0.26 | Met |
Sep. 30 2025 | 1.24 | 1.08 | Missed |
Recent news on Ashland
See all newsEvonik remains opposed to takeover offer after meeting BASF, says source familiar with the matter
Evonik still against takeover by BASF after talks, Handelsblatt reports
Evonik remains opposed to BASF bid after meeting, says person familiar with the matter (updated)
BASF, Evonik management held talks over weekend, says person familiar with matter
US RESEARCH ROUNDUP-Cencora, Dave, Uber